The DEA banned a drug some opioid users called a miracle

The US DEA has banned the opioid treatment compound SR-17018, a Schedule I controlled substance, which could hinder further research on its potential as a safer pain reliever. Researchers have found that SR-17018 can relieve pain in mice without causing respiratory depression and does not lead to tolerance or withdrawal symptoms. Online users have referred to it as a 'godsend' for quitting opioid addiction. The DEA's ban has halted clinical trials and research on the compound, making it harder for scientists to study its safety and potential medical use.